2. Product Overview II-32
Cancer: A Major Health Crises in the Modern World II-32
Table 21: Cancer Causes in Developed and Developing Countries
(2006): Percentage Breakdown by Risk Factors - Diet or
Nutrition, Infections, Tobacco, and Other Factors (includes
corresponding Graph/Chart) II-32
Types of Cancers II-32
Prostate Cancer II-33
Key Prostate Cancer Drugs & Companies II-33
Breast Cancer II-33
Key Breast Cancer Drugs & Companies II-34
Cervical Cancer II-34
Colorectal Cancer II-34
Key Colorectal Cancer Drugs & Companies II-35
Lung Cancer II-35
Key Lung Cancer Dugs & Companies II-36
Renal Cancer II-36
Key Renal Cancer Drugs and Companies II-36
Skin Cancer II-36
Non-Hodgkin's Lymphoma II-37
Leukemia II-37
Pancreatic Cancer II-37
Bladder Cancer II-37
Endometrial Cancer II-37
Cancer Therapies: A Review II-37
Monoclonal Antibodies Open Up A New Era in Cancer Treatment II-38
List of Approved Monoclonal Antibodies Used in Treating
Various Cancers II-38
Therapeutic Cancer Vaccines: Harnessing the Immune System to
Fight Cancer II-39
Cancer Vaccine Strategies II-39
Therapeutic Cancer Vaccine Products Under Clinical Trials
as of 2007 II-40
Gene Therapy II-40
Types of Cancer Therapies II-40
Chemotherapy II-40
Chemotherapy Drugs Require Careful Handling II-41
Types of Chemotherapy II-41
Chemotherapy Drug Classes II-42
Risks Associated with Chemotherapy II-42
When Chemotherapy Fails II-43
Targeted Therapy II-43
Table 22: Targeted Therapies Market Worldwide (2006):
Percentage Breakdown of Targeted Therapeutic Drugs Under
Various Stages of Development (incl
'/>"/>
| SOURCE Reportlinker Copyright©2009 PR Newswire. All rights reserved |